UGRO.NASDAQUrban-gro, INC

8-K: Urban-Gro Regains Nasdaq Compliance but Faces Minimum Bid and Equity Hurdles, Secures $4M Design Contract

Sentiment:

8-K Filing


Urban-Gro has regained compliance with Nasdaq's timely filing requirement but is now facing non-compliance issues related to minimum bid price and stockholders' equity, while also securing a $4 million contract for a new hospital design.

Delay expectedThe company delayed filing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024.The company delayed filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024.
Worse than expectedThe company is not in compliance with the Nasdaq Minimum Bid Requirement.The company is not in compliance with the Nasdaq Minimum Stockholders Equity Requirement.

Summary

  • Urban-Gro received a notice from Nasdaq on August 20, 2024, for not filing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024.
  • The company received another notice on November 21, 2024, for not filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024.
  • On February 18 and 19, 2025, Urban-Gro filed its overdue quarterly reports and amendments to previous reports, including restated financial statements.
  • As a result, on February 24, 2025, Nasdaq notified Urban-Gro that it had regained compliance with the timely filing requirement.
  • On February 24, 2025, Urban-Gro received a deficiency letter from Nasdaq because its common stock had closed below $1.00 per share for the last 30 consecutive business days, violating the Minimum Bid Requirement.
  • Urban-Gro has 180 calendar days, until August 25, 2025, to regain compliance with the Minimum Bid Requirement by maintaining a closing bid price of at least $1.00 per share for a minimum of ten consecutive trading days.
  • The company also received a deficiency letter on February 24, 2025, for not meeting the Minimum Stockholders Equity Requirement of $2.5 million, as reported on the Quarterly Report for the quarter ended September 30, 2024.
  • Urban-Gro has 45 calendar days, until April 10, 2025, to submit a plan to regain compliance with the Minimum Stockholders Equity Requirement, and if the plan is accepted, Nasdaq may grant an extension until August 25, 2025.
  • On February 26, 2025, Urban-Gro announced it has signed a professional services agreement valued at approximately $4 million to serve as the lead designer for a new hospital in the southeastern U.S.
  • The phase one project construction value is anticipated to be $80 million, and Urban-Gro expects to recognize the majority of the project's revenue this year.

Sentiment

Score: 4

Explanation: The sentiment is mixed. While securing a $4 million contract is positive, the non-compliance with Nasdaq listing requirements raises concerns about the company's financial health and future prospects. The delays in filing reports also contribute to a negative sentiment.

Positives

  • Urban-Gro regained compliance with Nasdaq's timely filing requirement.
  • The company secured a $4 million contract to serve as the lead designer for a new hospital, with an anticipated $80 million phase one construction value.
  • Urban-Gro anticipates recognizing the majority of the $4 million project revenue this year.

Negatives

  • Urban-Gro is not in compliance with the Nasdaq Minimum Bid Requirement, as its stock price has been below $1.00 for 30 consecutive business days.
  • Urban-Gro is not in compliance with the Nasdaq Minimum Stockholders Equity Requirement of $2.5 million.

Risks

  • There is no assurance that Urban-Gro will be able to regain compliance with the Minimum Bid Requirement or the Minimum Stockholders Equity Requirement.
  • Failure to regain compliance with Nasdaq listing standards could result in delisting of the company's common stock.
  • The company's ability to accurately forecast revenues and costs is subject to risks and uncertainties.
  • Delays in granting licenses to clients or potential clients and delays in passage of legislation could negatively impact the company.
  • Adverse weather conditions, supply chain issues, rising interest rates, and economic downturn could cause delays or cancellation of projects.
  • Reliance on key customers and suppliers poses a risk to the company's operations.
  • The company's ability to attract and retain key personnel is subject to risk.
  • Risks related to the company's information technology systems and infrastructure could impact operations.

Future Outlook

Urban-Gro anticipates recognizing the majority of the $4 million project revenue this year and will also provide master planning and design services for an additional eighty acres of development in future phases.

Management Comments

  • Bradley Nattrass, Chairman and CEO of urban-gro, stated, 'We look forward to utilizing our deep knowledge and understanding of the intricacies that come with healthcare design to help shape this new medical center.'
  • He added, 'Our teams innovative approach thoughtfully integrates functionality with a human-centered focus, ensuring a high quality and compassionate healthcare experience for all who interact with the space.'

Industry Context

The contract win in the healthcare sector diversifies Urban-Gro's portfolio, which traditionally focuses on Controlled Environment Agriculture (CEA) and industrial sectors, indicating a strategic move to leverage its design and build expertise across multiple industries.

Comparison to Industry Standards

  • While the document does not provide specific comparisons to industry standards, companies like AECOM, Jacobs Engineering Group, and HDR are major players in the architectural and engineering design space for healthcare facilities.
  • A $4 million design contract for an $80 million construction project is within the typical range for architectural services, which generally fall between 4% and 8% of the total construction cost.
  • However, without knowing the specific scope of services and the complexity of the project, it's difficult to make a precise comparison.

Stakeholder Impact

  • Shareholders face the risk of delisting if Urban-Gro fails to regain compliance with Nasdaq listing standards, potentially impacting the value of their investment.
  • Employees may experience uncertainty due to the company's financial challenges and potential delisting.
  • Customers may be impacted if the company's financial difficulties affect its ability to deliver projects and services.
  • Suppliers and creditors face increased risk if the company's financial situation deteriorates.

Next Steps

  • Urban-Gro must actively monitor its stock price to regain compliance with the Minimum Bid Requirement.
  • The company must submit a plan to Nasdaq by April 10, 2025, to regain compliance with the Minimum Stockholders Equity Requirement.
  • Urban-Gro will execute the professional services agreement for the new hospital design and recognize revenue from the project this year.
  • The company will continue to evaluate options to regain compliance with Nasdaq listing standards.

Key Dates

DateDescription
August 20, 2024Urban-Gro received a notice from Nasdaq for not filing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024.
November 21, 2024Urban-Gro received a notice from Nasdaq for not filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024.
February 18, 2025Urban-Gro filed its Quarterly Reports on Form 10-Q for the quarters ended June 30, 2024 and September 30, 2024 and an amendment to its Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
February 19, 2025Urban-Gro filed an amendment to its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024.
February 24, 2025Nasdaq notified Urban-Gro that it had regained compliance with the timely filing requirement; Urban-Gro received a deficiency letter from Nasdaq for not meeting the Minimum Bid Requirement and the Minimum Stockholders Equity Requirement.
February 26, 2025Urban-Gro announced it has signed a $4 million professional services agreement to serve as the lead designer for a new hospital.
February 28, 2025Date of report.
April 10, 2025Deadline for Urban-Gro to submit a plan to regain compliance with the Minimum Stockholders Equity Requirement.
August 25, 2025Expiration of the 180-day compliance period for the Minimum Bid Requirement; potential extension deadline for regaining compliance with the Minimum Stockholders Equity Requirement.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.